|Systematic (IUPAC) name|
|(what is this?)|
Alanosine (also called SDX-102) is a substance that is being studied for the treatment of pancreatic cancer. It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.
|This antiinfective drug article is a stub. You can help Wikipedia by expanding it.|